zolpidem has been researched along with triazolam in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.47) | 18.7374 |
1990's | 39 (48.15) | 18.2507 |
2000's | 25 (30.86) | 29.6817 |
2010's | 14 (17.28) | 24.3611 |
2020's | 1 (1.23) | 2.80 |
Authors | Studies |
---|---|
Cook, JM; Dayer, CA; He, X; Huang, Q; Liu, R; Ma, C; McKernan, R; Wenger, GR; Yu, S | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ator, NA; Brady, JV; Griffiths, RR; Sannerud, CA | 1 |
Arbilla, S; Benavides, J; Durand, A; Peny, B; Scatton, B | 1 |
Coleman, BS; Jonas, JM; Kalinske, RW; Sheridan, AQ | 1 |
Sanger, DJ; Zivkovic, B | 1 |
Balkin, TJ; Belenky, G; McCann, U; O'Donnell, VM; Wesensten, N | 1 |
Cooper, M; Hoffmann, WE; Piercey, MF | 1 |
Critchfield, TS; Evans, SM; Griffiths, RR | 1 |
Evans, SM; Funderburk, FR; Griffiths, RR | 1 |
Aubier, M; Murciano, D; Palacios, S; Pariente, R | 1 |
Evans, SM; Griffiths, RR | 1 |
Joly, D; Sanger, DJ; Zivkovic, B | 1 |
Balkin, TJ; Belenky, GL; Wesensten, NJ | 2 |
Cohen, C; Sanger, DJ | 1 |
Merlotti, L; Roehrs, T; Roth, T; Zorick, F | 1 |
Attali, P; de la Giclais, B; Monti, D; Monti, JM; Morselli, PL; Zipfel, A | 1 |
Ahlstrøm, F; Rosenberg, J | 1 |
Bagot, C; Berlin, I; Hergueta, T; Molinier, P; Puech, AJ; Warot, D | 1 |
Armengaud, MH; Aubier, M; Cramer, PH; L'Héritier, C; Murciano, D; Neveux, E; Pariente, R | 1 |
Balkin, TJ; Belenky, GL; Davis, HQ; Wesensten, NJ | 1 |
Griffiths, RR; Rush, CR | 1 |
Meier-Abt, PJ; Radovanovic, D; Wyss, PA | 1 |
Hadingham, KL; Palmer, KJ; Thompson, SA; Wafford, KA; Whiting, PJ | 1 |
Rowlett, JK; Woolverton, WL | 1 |
Goldman, NH; Madakasira, S; Rowlett, JK; Rush, CR; Woolverton, WL | 1 |
Chapados, R; Chung, FF; Gauthier, M; Knox, JW; Le Lorier, J; Morgan, PJ | 1 |
Roehrs, T; Roth, T; Scharf, MB; Vogel, GW; Walsh, JK; Ware, JC | 1 |
Greene, WL; Lobo, BL | 2 |
Boselli, M; Parrino, L; Smerieri, A; Spaggiari, MC; Terzano, MG | 1 |
Allard, S; Holt, RJ | 1 |
Ali, JA; Armstrong, DL; Pazzaglia, PJ; Rush, CR | 1 |
Frey, JM; Griffiths, RR; Mintzer, MZ; Yingling, JE | 1 |
Frey, JM; Griffiths, RR; Mintzer, MZ | 1 |
Griebel, G; Perrault, G; Sanger, DJ | 1 |
Higuchi, H; Hishikawa, Y; Kamata, M; Shimizu, T; Yoshida, K; Yoshimoto, M | 1 |
Griffiths, RR; Mintzer, MZ | 1 |
Higuchi, H; Hishikawa, Y; Shimizu, T; Takahashi, H; Yoshimoto, M | 1 |
Baker, RW; Rush, CR; Wright, K | 1 |
Carter, RB; Edgar, DM; Fick, DB; Gee, KW; Hogenkamp, DJ; Lan, NC; Seidel, WF; Vanover, KE | 1 |
Berger, M; Feige, B; Hohagen, F; Riemann, D; Voderholzer, U | 1 |
Baker, RW; Rowlett, JK; Rush, CR | 1 |
Durol, AL; Greenblatt, DJ; Harmatz, JS; Harrel-Joseph, LM; Shader, RI; von Moltke, LL; Wright, CE | 1 |
Cevallos, WH; Furlan, PM; Leister, CA; Lucki, I; Mangano, R; Martin, PT; Troy, SM; Unruh, MA | 1 |
Daily, JP; Durol, AL; Graf, JA; Greenblatt, DJ; Harmatz, JS; Hoffman, JL; Mertzanis, P; Shader, RI; von Moltke, LL | 1 |
Lelas, S; Rowlett, JK; Spealman, RD | 1 |
Akaho, R; Ichikawa, I; Kanno, O; Nakagome, K; Nakajima, T; Sasaki, T; Suzuki, M; Takazawa, S; Watanabe, H | 1 |
Bickel, WK; Smith, BJ | 1 |
Cook, JM; Ma, C; Miczek, KA; Rowlett, JK; Tornatzky, W | 1 |
Backhaus, J; Berger, M; Feige, B; Hohagen, F; Hornyak, M; Riemann, D; Voderholzer, U | 1 |
Biggio, G; Busonero, F; Carta, M; Maciocco, E; Massa, F; Peis, M; Sanna, E; Talani, G | 1 |
Cook, J; Ma, C; Platt, DM; Rowlett, JK; Spealman, RD | 1 |
Rush, CR; Stoops, WW | 1 |
Kulkarni, SK; Kumar, A | 1 |
Foster, AC; Grigoriadis, DE; Gross, RS; Petroski, RE; Sullivan, SK; Verge, G | 1 |
Chen, HY; Kuo, TB; Lai, CJ; Shaw, FZ; Yang, CC | 1 |
Ishii, M; Ito, H; Nakamura, M; Niwa, Y; Yamazaki, M | 1 |
Boric, K; Cárdenas, AM; Galli, I; Henríquez-Roldán, CF; Meléndez, J; Ortega, A; Zuñiga, L | 1 |
Cabodi, S; Cotroneo, A; De Sarro, G; Gareri, P; Grassone, D; Lacava, R; Maina, E; Nicoletti, N | 1 |
Aton, SJ; Coleman, T; Dumoulin, MC; Frank, MG; Jha, SK; Seibt, J | 1 |
Echizenya, M; Iwaki, S; Shimizu, T; Suda, H | 1 |
Kehne, JH; Malison, RT; Morgan, PT; Sprenger, KJ | 1 |
Marin, SJ; McMillin, GA; Roberts, M; Wood, M | 1 |
Greenblatt, DJ; Zammit, GK | 1 |
Cook, JM; Makaron, L; Moran, CA; Namjoshi, O; Rallapalli, S; Rowlett, JK | 1 |
Ator, NA; Biawat, P; Clayton, T; Cook, JM; Rallapalli, SK; Soto, PL; Weed, MR | 1 |
Darnell, SB; Huizenga, MN; Licata, SC; Rowlett, JK; Rudolph, U; Sadri-Vakili, G; Sangrey, GR; Shinday, NM | 1 |
In, MK; Jeong, YD; Kim, JY; Kim, MK; Paeng, KJ; Suh, SI | 1 |
Ito, W; Kanbayashi, T; Nishino, S; Satake, M; Shimizu, K; Shimizu, T; Shioya, T; Uemura, SI; Wakasa, M | 1 |
Fukase, Y; Hakamata, Y; Kumagai, Y; Kuroyama, M; Matsunaga, Y; Murayama, N; Tagaya, H | 1 |
Puustinen, J | 1 |
Min, JY; Min, KB | 1 |
Ishikawa, A; Kakehashi, H; Kamata, T; Katagi, M; Nakano-Fujii, S; Nitta, A; Sasaki, K; Sato, T; Shima, N; Wada, M | 1 |
3 review(s) available for zolpidem and triazolam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comparative clinical profiles of triazolam versus other shorter-acting hypnotics.
Topics: Azabicyclo Compounds; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Hypnotics and Sedatives; Piperazines; Pyridines; Receptors, GABA-A; Sleep Initiation and Maintenance Disorders; Triazolam; Zolpidem | 1992 |
Zolpidem: distinct from triazolam?
Topics: Humans; Hypnotics and Sedatives; Pyridines; Sleep Initiation and Maintenance Disorders; Triazolam; Zolpidem | 1997 |
30 trial(s) available for zolpidem and triazolam
Article | Year |
---|---|
Comparison of the daytime sleep and performance effects of zolpidem versus triazolam.
Topics: Adolescent; Adult; Humans; Hypnotics and Sedatives; Male; Psychomotor Performance; Pyridines; Sleep; Triazolam; Wakefulness; Zolpidem | 1992 |
Abuse liability assessment of anxiolytics/hypnotics: rationale and laboratory lore.
Topics: Anti-Anxiety Agents; Dose-Response Relationship, Drug; Humans; Hypnotics and Sedatives; Pyridines; Risk Factors; Substance-Related Disorders; Triazolam; Zolpidem | 1991 |
Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
Topics: Adult; Behavior; Cognition; Dose-Response Relationship, Drug; Humans; Male; Psychomotor Performance; Pyridines; Substance-Related Disorders; Time Factors; Triazolam; Zolpidem | 1990 |
Zolpidem and triazolam in humans: behavioral effects and abuse liability.
Topics: Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypnotics and Sedatives; Mental Recall; Psychomotor Performance; Pyridines; Randomized Controlled Trials as Topic; Substance-Related Disorders; Triazolam; Zolpidem | 1989 |
Effects of daytime administration of zolpidem versus triazolam on memory.
Topics: Administration, Oral; Adolescent; Adult; Double-Blind Method; Humans; Hypnotics and Sedatives; Memory; Mental Recall; Polysomnography; Pyridines; Sleep; Time Factors; Triazolam; Zolpidem | 1995 |
Sedative, memory, and performance effects of hypnotics.
Topics: Adult; Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Electrooculography; Female; Humans; Hypnotics and Sedatives; Male; Memory; Polysomnography; Psychomotor Performance; Pyridines; Reaction Time; Triazolam; Zolpidem | 1994 |
Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
Topics: Adult; Aged; Anxiety; Chronic Disease; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Polysomnography; Psychiatric Status Rating Scales; Pyridines; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Triazolam; Zolpidem | 1994 |
Randomized, double blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice.
Topics: Adult; Aged; Circadian Rhythm; Double-Blind Method; Family Practice; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pyridines; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam; Zolpidem | 1994 |
Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
Topics: Adult; Double-Blind Method; Flicker Fusion; Humans; Hypnotics and Sedatives; Male; Mental Recall; Paired-Associate Learning; Pattern Recognition, Visual; Postural Balance; Posture; Psychomotor Performance; Pyridines; Reaction Time; Sensory Thresholds; Triazolam; Zolpidem | 1993 |
Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD.
Topics: Blood Gas Analysis; Carbon Dioxide; Flunitrazepam; Humans; Hypnotics and Sedatives; Lung Diseases, Obstructive; Middle Aged; Oxygen; Pyridines; Respiration; Triazolam; Zolpidem | 1993 |
Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil.
Topics: Administration, Oral; Adolescent; Adult; Flumazenil; Humans; Hypnotics and Sedatives; Male; Memory; Placebo Effect; Pyridines; Time Factors; Triazolam; Volunteers; Zolpidem | 1995 |
Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.
Topics: Adult; Anti-Anxiety Agents; Arousal; Attention; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Pyridines; Serial Learning; Temazepam; Triazolam; Zolpidem | 1996 |
Effects of daytime administration of zolpidem and triazolam on performance.
Topics: Adult; Cognition; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypnotics and Sedatives; Male; Pyridines; Triazolam; Zolpidem | 1996 |
Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
Topics: Adult; Caffeine; Discrimination Learning; Dose-Response Relationship, Drug; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pentobarbital; Pyridines; Triazolam; Zolpidem | 1997 |
Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery.
Topics: Adult; Aged; Analysis of Variance; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Preanesthetic Medication; Pyridines; Sleep; Triazolam; Zolpidem | 1997 |
Minimal rebound insomnia after treatment with 10-mg zolpidem.
Topics: Adult; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Polysomnography; Pyridines; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Triazolam; Zolpidem | 1997 |
Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern.
Topics: Adult; Azabicyclo Compounds; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Piperazines; Polysomnography; Pyridines; Sex Factors; Sleep Initiation and Maintenance Disorders; Triazolam; Zolpidem | 1997 |
Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects.
Topics: Acute Disease; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; GABA Modulators; Humans; Hypnotics and Sedatives; Learning; Ligands; Male; Mental Recall; Middle Aged; Psychomotor Performance; Pyridines; Receptors, GABA-A; Sleep Stages; Surveys and Questionnaires; Triazolam; Zolpidem | 1998 |
Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.
Topics: Adult; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Mental Recall; Psychomotor Performance; Pyridines; Time Perception; Triazolam; Zolpidem | 1997 |
Triazolam and zolpidem: effects on human memory and attentional processes.
Topics: Adult; Analysis of Variance; Attention; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypnotics and Sedatives; Male; Memory; Middle Aged; Psychomotor Performance; Pyridines; Time Factors; Triazolam; Zolpidem | 1999 |
Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects.
Topics: Adult; Azabicyclo Compounds; Double-Blind Method; Electroencephalography; Humans; Hypnotics and Sedatives; Male; Piperazines; Polysomnography; Pyridines; Sleep; Substance Withdrawal Syndrome; Triazolam; Zolpidem | 1999 |
Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Cues; Discrimination Learning; Discrimination, Psychological; Female; Humans; Hypnotics and Sedatives; Male; Mental Recall; Pentobarbital; Psychomotor Performance; Pyridines; Surveys and Questionnaires; Triazolam; Zolpidem | 2000 |
Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.
Topics: Adult; Affect; Area Under Curve; Chromatography, Gas; Cross-Over Studies; Double-Blind Method; Electroencephalography; Female; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; Half-Life; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychomotor Performance; Pyridines; Sex Characteristics; Triazolam; Zolpidem | 2000 |
Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
Topics: Acetamides; Adolescent; Adult; Affect; Association Learning; Attention; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Learning; Male; Memory; Mental Recall; Middle Aged; Psychomotor Performance; Pyridines; Pyrimidines; Sex Characteristics; Surveys and Questionnaires; Triazolam; Zolpidem | 2000 |
Differential impairment of triazolam and zolpidem clearance by ritonavir.
Topics: Adult; Anti-Anxiety Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Half-Life; HIV Protease Inhibitors; HIV Seronegativity; Humans; Hypnotics and Sedatives; Male; Metabolic Clearance Rate; Oxidoreductases, N-Demethylating; Pyridines; Ritonavir; Triazolam; Zolpidem | 2000 |
Comparison of the effects of zolpidem and triazolam on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers.
Topics: Adult; Affect; Anti-Anxiety Agents; Cross-Over Studies; Humans; Hypnotics and Sedatives; Male; Pyridines; Sleep; Sleep Wake Disorders; Triazolam; Zolpidem | 2000 |
A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
Topics: Adult; Azabicyclo Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Humans; Hypnotics and Sedatives; Male; Piperazines; Polysomnography; Pyridines; Reference Values; Sleep; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Triazolam; Zolpidem | 2001 |
Temporal changes in postural sway caused by ultrashort-acting hypnotics: triazolam and zolpidem.
Topics: Accidental Falls; Adult; Double-Blind Method; Gait; Humans; Hypnotics and Sedatives; Male; Posture; Pyridines; Time Factors; Triazolam; Zolpidem | 2005 |
Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement.
Topics: Administration, Oral; Adult; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypnotics and Sedatives; Male; Mental Recall; Neuropsychological Tests; Pyridines; Sleep; Statistics as Topic; Triazolam; Vocabulary; Zolpidem | 2005 |
Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study.
Topics: Aged; Cross-Over Studies; Double-Blind Method; Female; Healthy Volunteers; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychomotor Performance; Pyridines; Triazolam; Triazoles; Zolpidem | 2015 |
48 other study(ies) available for zolpidem and triazolam
Article | Year |
---|---|
Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
Topics: Animals; Benzodiazepines; Carbolines; Cell Line; Columbidae; Conditioning, Operant; Crystallography, X-Ray; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quinolones; Radioligand Assay; Receptors, GABA-A; Saimiri; Stereoisomerism; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal.
Topics: Animals; Barbiturates; Cocaine; Discrimination Learning; Drug Tolerance; Hypnotics and Sedatives; Male; Papio; Pyridines; Receptors, GABA-A; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam; Zolpidem | 1992 |
Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
Topics: Animals; Benzodiazepines; Binding Sites; Binding, Competitive; Brain Chemistry; Cell Membrane; Central Nervous System; Flumazenil; Hypnotics and Sedatives; Pyridazines; Pyridines; Rats; Receptors, GABA-A; Triazolam; Zolpidem | 1992 |
Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors.
Topics: Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Binding Sites; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Tolerance; Male; Midazolam; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Reinforcement, Psychology; Triazolam; Zolpidem | 1992 |
The hypnotics triazolam and zolpidem have identical metabolic effects throughout the brain: implications for benzodiazepine receptor subtypes.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Energy Metabolism; Hypnotics and Sedatives; Male; Organ Specificity; Pyridines; Rats; Rats, Inbred Strains; Receptors, GABA-A; Spinal Cord; Triazolam; Zolpidem | 1991 |
Comparison of zolpidem (Z), triazolam (T), and flunitrazepam (F) effects on arterial blood gases and control of breathing in patients with severe chronic obstructive pulmonary disease (COPD).
Topics: Flunitrazepam; Humans; Hypnotics and Sedatives; Lung Diseases, Obstructive; Pyridines; Respiratory Center; Triazolam; Zolpidem | 1990 |
Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice. Comparison with triazolam and CL 218,872.
Topics: Animals; Anti-Anxiety Agents; Conditioning, Operant; Fear; Hypnotics and Sedatives; Male; Mice; Motor Activity; Pyridazines; Pyridines; Triazolam; Zolpidem | 1986 |
Effects of chronic treatment with triazolam on operant responding in rats.
Topics: Animals; Conditioning, Operant; Drug Tolerance; Flumazenil; Hypnotics and Sedatives; Male; Pyridines; Rats; Rats, Wistar; Reinforcement Schedule; Time Factors; Triazolam; Zolpidem | 1994 |
[Acute overdose of Zolpidem (Stilnox)].
Topics: Adolescent; Adult; Aged; Antidotes; Coma; Drug Overdose; Female; Flumazenil; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Pyridines; Retrospective Studies; Triazolam; Zolpidem | 1996 |
Expression and pharmacology of human GABAA receptors containing gamma 3 subunits.
Topics: Amino Acid Sequence; Animals; Anti-Anxiety Agents; Base Sequence; Benzodiazepines; Benzodiazepinones; Carbolines; Flumazenil; Flunitrazepam; GABA Modulators; Humans; Molecular Sequence Data; Pyrazoles; Pyridazines; Pyridines; Receptors, GABA-A; Recombinant Proteins; Sequence Homology, Amino Acid; Triazolam; Xenopus; Zolpidem | 1995 |
Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Female; Hypnotics and Sedatives; Macaca mulatta; Male; Pentobarbital; Pyridines; Rats; Rats, Sprague-Dawley; Species Specificity; Triazolam; Zolpidem | 1997 |
Insomnia.
Topics: Humans; Hypnotics and Sedatives; Pyridines; Sleep Initiation and Maintenance Disorders; Triazolam; Zolpidem | 1997 |
Comment: zolpidem: distinct from triazolam?
Topics: Humans; Hypnotics and Sedatives; Pyridines; Sleep Initiation and Maintenance Disorders; Triazolam; Zolpidem | 1997 |
Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure.
Topics: Adult; Cognition; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Humans; Hypnotics and Sedatives; Male; Psychomotor Performance; Pyridines; Surveys and Questionnaires; Time Factors; Triazolam; Zolpidem | 1998 |
Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
Topics: Acetamides; Animals; Anti-Anxiety Agents; Avoidance Learning; Azabicyclo Compounds; Benzodiazepines; Escape Reaction; Hypnotics and Sedatives; Male; Maze Learning; Motor Activity; Piperazines; Punishment; Pyridines; Pyrimidines; Rats; Rats, Wistar; Triazolam; Zolpidem | 1998 |
The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats.
Topics: Animals; Azabicyclo Compounds; Hypnotics and Sedatives; Male; Piperazines; Pyridines; Rats; Rats, Wistar; Sleep; Sleep, REM; Theta Rhythm; Triazolam; Wakefulness; Zolpidem | 1999 |
Different effects of L-type and T-type calcium channel blockers on the hypnotic potency of triazolam and zolpidem in rats.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Channels, T-Type; Drug Interactions; Flunarizine; Hypnotics and Sedatives; Male; Nifedipine; Pyridines; Rats; Rats, Wistar; Sleep, REM; Triazolam; Zolpidem | 1999 |
Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
Topics: Adult; Antidepressive Agents, Tricyclic; Humans; Hypnotics and Sedatives; Male; Memory; Mental Recall; Postural Balance; Psychomotor Performance; Pyridines; Substance-Related Disorders; Surveys and Questionnaires; Time Factors; Trazodone; Triazolam; Zolpidem | 1999 |
Response-rate suppression in operant paradigm as predictor of soporific potency in rats and identification of three novel sedative-hypnotic neuroactive steroids.
Topics: Animals; Conditioning, Operant; Depression, Chemical; Dose-Response Relationship, Drug; Electroencephalography; Hypnotics and Sedatives; Male; Pentobarbital; Postural Balance; Pregnanolone; Pregnenolone; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Steroids; Triazolam; Zolpidem | 1999 |
Transduction of the discriminative stimulus effects of zolpidem by GABA(A)/alpha1 receptors.
Topics: Acetamides; Animals; Diazepam; Discrimination, Psychological; Dose-Response Relationship, Drug; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; Male; Protein Subunits; Pyridines; Pyrimidines; Reinforcement Schedule; Saimiri; Triazolam; Zolpidem | 2000 |
Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo.
Topics: Adolescent; Adult; Alprazolam; Analysis of Variance; Caffeine; Discrimination, Psychological; Female; GABA Agonists; GABA Modulators; Humans; Male; Phosphodiesterase Inhibitors; Pyridines; Triazolam; Zolpidem | 2001 |
Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt).
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Body Temperature; Carbolines; Diazepam; Dose-Response Relationship, Drug; Flumazenil; GABA-A Receptor Antagonists; Mice; Pyridines; Receptors, GABA-A; Triazolam; Vocalization, Animal; Zolpidem | 2001 |
Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
Topics: Acetamides; Animals; Cerebral Cortex; Female; Humans; Male; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Triazolam; Xenopus laevis; Zolpidem | 2002 |
Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
Topics: Animals; Ataxia; Benzodiazepines; Carbolines; Dose-Response Relationship, Drug; Drug Interactions; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Antagonists; Male; Motor Activity; Pyridines; Receptors, GABA-A; Saimiri; Social Behavior; Triazolam; Zolpidem | 2002 |
Differential effects in humans after repeated administrations of zolpidem and triazolam.
Topics: Adult; Female; GABA Agonists; GABA Modulators; Humans; Male; Memory; Mental Recall; Psychomotor Performance; Pyridines; Surveys and Questionnaires; Time Factors; Triazolam; Zolpidem | 2003 |
On the sleep promoting effects of BR-16A: interaction with GABAergic modulators.
Topics: Alprazolam; Animals; Dose-Response Relationship, Drug; Drug Interactions; Female; GABA Agonists; GABA Modulators; Hypnosis; Hypnotics and Sedatives; Male; Medicine, Ayurvedic; Melatonin; Mice; Plant Extracts; Pyridines; Sleep; Sleep Initiation and Maintenance Disorders; Time Factors; Triazolam; Zolpidem | 2004 |
Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor.
Topics: Acetamides; Animals; Azides; Benzodiazepines; Binding Sites; Brain; Cell Membrane; Cerebellum; Cerebral Cortex; Chloride Channels; Flumazenil; GABA Modulators; gamma-Aminobutyric Acid; Kinetics; Male; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Thiophenes; Triazolam; Tritium; Zolpidem | 2004 |
Sleep-related vagotonic effect of zolpidem in rats.
Topics: Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; Electroencephalography; Electromyography; Heart Rate; Hypnotics and Sedatives; Male; Pyridines; Rats; Rats, Inbred WKY; Sleep; Sleep, REM; Spectrum Analysis; Time Factors; Triazolam; Vagus Nerve; Zolpidem | 2005 |
Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people.
Topics: Aged; Cognition Disorders; Dementia; Depression; Drug Administration Schedule; Female; Health Status; Humans; Hypnotics and Sedatives; Male; Neuropsychological Tests; Oxazepam; Primary Health Care; Psychomotor Agitation; Pyridines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazolam; Zolpidem | 2007 |
The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity.
Topics: Animals; Brain Mapping; Cats; Cerebral Cortex; Dominance, Cerebral; Dose-Response Relationship, Drug; Electroencephalography; Evoked Potentials, Visual; Female; Hypnotics and Sedatives; Indenes; Injections, Intraperitoneal; Male; Neuronal Plasticity; Polysomnography; Pyridines; Signal Processing, Computer-Assisted; Sleep; Sleep Stages; Tomography, Optical Coherence; Triazolam; Zolpidem | 2008 |
Paradoxical reactions to hypnotic agents in adolescents with free-running disorder.
Topics: Adolescent; Anti-Anxiety Agents; Azepines; Dyskinesia, Drug-Induced; Female; Humans; Hypnotics and Sedatives; Male; Pyridines; Sleep Disorders, Circadian Rhythm; Triazolam; Zolpidem | 2009 |
Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans.
Topics: Adult; Arousal; Cognition Disorders; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Humans; Hypnotics and Sedatives; Learning; Male; Memory; Middle Aged; Movement; Polysomnography; Pyridines; Reaction Time; Sleep Initiation and Maintenance Disorders; Sleep Stages; Triazolam; Zolpidem | 2010 |
Sensitive UPLC-MS-MS assay for 21 benzodiazepine drugs and metabolites, zolpidem and zopiclone in serum or plasma.
Topics: Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Humans; Liquid-Liquid Extraction; Lorazepam; Mass Spectrometry; Nordazepam; Oxazepam; Piperazines; Plasma; Pyridines; Serum; Specimen Handling; Tandem Mass Spectrometry; Temazepam; Triazolam; Zolpidem | 2012 |
Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications.
Topics: Acetamides; Adult; Aged; Azabicyclo Compounds; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Eszopiclone; Half-Life; Hepatic Insufficiency; Humans; Hypnotics and Sedatives; Piperazines; Pyridines; Pyrimidines; Receptors, GABA-A; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam; United States; Zolpidem | 2012 |
Cognition-impairing effects of benzodiazepine-type drugs: role of GABAA receptor subtypes in an executive function task in rhesus monkeys.
Topics: Acetamides; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Carbolines; Cognition; Executive Function; Female; GABA-A Receptor Antagonists; Hypnotics and Sedatives; Imidazoles; Macaca mulatta; Pyridines; Pyrimidines; Receptors, GABA-A; Triazolam; Zolpidem | 2013 |
Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected].
Topics: Acetamides; Allosteric Regulation; Animals; Benzodiazepines; Conditioning, Operant; Diazepam; Dose-Response Relationship, Drug; Imidazoles; Macaca mulatta; Male; Memory, Short-Term; Pyridazines; Pyridines; Pyrimidines; Receptors, GABA-A; Recognition, Psychology; Triazolam; Triazoles; Zolpidem | 2013 |
Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment.
Topics: Analysis of Variance; Animals; Benzodiazepines; Blotting, Western; Brain-Derived Neurotrophic Factor; Chromatin Immunoprecipitation; Cyclic AMP Response Element-Binding Protein; Diazepam; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Genes, Immediate-Early; Hippocampus; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-fos; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Triazolam; Zolpidem | 2013 |
Rapid determination of benzodiazepines, zolpidem and their metabolites in urine using direct injection liquid chromatography-tandem mass spectrometry.
Topics: Alprazolam; Benzodiazepines; Chromatography, Liquid; Flurazepam; Forensic Toxicology; Humans; Hypnotics and Sedatives; Limit of Detection; Pyridines; Tandem Mass Spectrometry; Triazolam; Zolpidem | 2015 |
Effects of zolpidem/triazolam on cognitive performance 12 hours after acute administration.
Topics: Adult; Anti-Anxiety Agents; Cognition; Humans; Male; Neuropsychological Tests; Polysomnography; Sleep Aids, Pharmaceutical; Triazolam; Young Adult; Zolpidem | 2018 |
Benzodiazepines and Z-drugs may cause prolonged cognitive issues in young adults - are hypnotics not only a geriatric dilemma?
Topics: Aged; Benzodiazepines; Cognition; Humans; Hypnotics and Sedatives; Pharmaceutical Preparations; Triazolam; Young Adult; Zolpidem | 2018 |
Outdoor Artificial Nighttime Light and Use of Hypnotic Medications in Older Adults: A Population-Based Cohort Study.
Topics: Age Factors; Aged; Cohort Studies; Drug Utilization Review; Female; Humans; Hypnotics and Sedatives; Lighting; Male; Middle Aged; Republic of Korea; Risk Factors; Sleep Initiation and Maintenance Disorders; Triazolam; Zolpidem | 2018 |
Incorporation of five common hypnotics into hair after a single dose and application to a forensic case of drug facilitated crimes.
Topics: Adult; Asian People; Chromatography, Liquid; Crime; Diazepam; Female; Flunitrazepam; Forensic Toxicology; Hair; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Nitrazepam; Substance Abuse Detection; Triazolam; Zolpidem | 2021 |